A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium

Messenger RNA (mRNA) lipid nanoparticle (LNP) vaccines have emerged as an effective vaccination strategy. Although currently applied toward viral pathogens, data concerning the platform’s effectiveness against bacterial pathogens are limited. Here, we developed an effective mRNA-LNP vaccine against...

Descripción completa

Detalles Bibliográficos
Autores principales: Kon, Edo, Levy, Yinon, Elia, Uri, Cohen, Hila, Hazan-Halevy, Inbal, Aftalion, Moshe, Ezra, Assaf, Bar-Haim, Erez, Naidu, Gonna Somu, Diesendruck, Yael, Rotem, Shahar, Ad-El, Nitay, Goldsmith, Meir, Mamroud, Emanuelle, Peer, Dan, Cohen, Ofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995031/
https://www.ncbi.nlm.nih.gov/pubmed/36888708
http://dx.doi.org/10.1126/sciadv.adg1036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995031/
https://www.ncbi.nlm.nih.gov/pubmed/36888708
http://dx.doi.org/10.1126/sciadv.adg1036

Ejemplares similares